-
Biden administration looks at expanding OTC medication coverage
The Biden administration is aiming to expand insurance coverage for certain over-the-counter medications, including contraception, The Hill reported Oct. 2. -
6 pressing drug shortages, per pharmacy technicians
More than 9 in 10 pharmacy technicians are experiencing workflow challenges and about 45 percent said they're unable to administer prescriptions because of drug shortages, according to a recent survey. -
Kaiser pharmacy workers begin 3-week strike
Hundreds of pharmacy technicians, pharmacy clerks and pharmacy warehouse employees at Kaiser Permanente began picketing Oct. 1 in a strike planned to last through Oct. 21. -
CVS pharmacists return to work
CVS pharmacists protesting challenging working conditions in Kansas City returned to work Sept. 28 after CVS leaders vowed to make numerous improvements, USA Today reported. -
Senator probes Cleveland Clinic, Bon Secours over 340B program
Louisiana Sen. Bill Cassidy, MD, opened an investigation Sept. 28 into how Cleveland Clinic and a Bon Secours hospital is involved in the 340B drug pricing program. -
4 tips for pharmacists looking to join hospital C-suites
Compared to COOs and CFOs, the pathway from pharmacy leader to a hospital C-suite is less established. Here's how four hospital C-suite executives with pharmacy backgrounds rose through the ranks. -
FDA panel votes against controversial ALS drug candidate
FDA advisers on Sept. 27 voted against recommending an experimental treatment for Lou Gehrig's disease. -
FDA updates Ozempic label to mention intestinal blockage side effect
The label for Novo Nordisk's weight loss drug Ozempic now acknowledges some users' reports of ileus, or intestinal blockage. -
More than 9M Ozempic, GLP-1 prescriptions written in Q4 2022
In the last three months of 2022, physicians signed more than 9 million prescriptions for obesity drug Saxenda and two diabetes medications, Ozempic and Mounjaro, according to a report by Trilliant Health, a data analytics company. -
Cigna's Accredo plans major expansion in Delaware
Accredo Health Group, a specialty pharmacy owned by the Cigna Group, is planning to expand its business in Delaware, the Delaware Business Times reported Sept. 25. -
FDA warns manufacturers to test for contaminants tied to global deaths: Reuters
The FDA has issued warnings to at least 28 manufacturers of over-the-counter medications and health products this year for failing to adequately test ingredients for toxins that caused hundreds of deaths overseas, according to a Sept. 26 exclusive report from Reuters. -
340B program climbs to $54B
From 2021 to 2022, the 340B drug pricing program grew 22 percent, according to a Sept. 24 Drug Channels report. -
CVS pharmacists voice concern over working conditions
Some CVS pharmacists in Kansas City are calling out of work Sept. 27 to bring attention to increasingly difficult working conditions, USA Today reported. -
Cancer drugs in shortage: 15 supply updates
One cancer drug shortage has ended and at least 14 oncology drugs are in short supply, according to the FDA, the American Society of Health-System Pharmacists and physicians. -
Weight-loss drug market could reach $100B by 2035
The market for drugs like Eli Lilly's Mounjaro and Novo Nordisk's Ozempic and Wegovy is projected to reach $100 billion by 2035, Fortune reported Sept. 22. -
VCU energizes its pharmacy plan
VCU Health is doubling down on its pharmacy strategy and mail-order medication services, according to Michael Roussos, president of VCU Medical Center. -
Florida hospital treats DMD patient with new, $3.2M gene therapy
For the first time in Florida, physicians administered a recently approved gene therapy for Duchenne muscular dystrophy to a pediatric patient. -
Pediatric cancer drugs in short supply
As the supply of two staple cancer drugs rebounds after months of scarcity, two medications used in pediatric cancer patients have fallen into shortage, NBC News reported Sept. 25. -
Pfizer restarts production at North Carolina plant hit by tornado
Production has resumed at Pfizer's 1.4 million square foot manufacturing plant that was damaged in July by a tornado, the company announced Sept. 25. -
Ulcer drug recalled amid contamination risk
A Florida-based drugmaker is pulling one lot of an ulcer drug because of a possible Bacillus cereus contamination.
Page 1 of 50